MedTrace Logo

A Trial to Reduce Delirium in Aged Post Acute Patients

NCT00182936 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2006-11-20

No results posted yet for this study

Summary

The purpose of this study is to develop a comprehensive Delirium Abatement Program of care of delirious patients in the post acute care setting and to evaluate its impact on persistence and severity of delirium and on functional recovery.

Conditions

  • Delirium
  • Aging

Interventions

BEHAVIORAL

Delirium Abatement Program

Sponsors & Collaborators

  • Paul B. Beeson Career Development Awards in Aging Research Program

    collaborator UNKNOWN

  • National Institute on Aging (NIA)

    lead NIH

Principal Investigators

  • Edward Marcantonio, MD, SM · Beth Israel Deaconess Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-05-31
Completion
2004-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00182936 on ClinicalTrials.gov